Active ingredients: ceftazidime
What it is used for
Treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. Indications include the folowing: Severe infections in general (e.g. septicaemia including neonatal sepsis, bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns). Respiratory tract (e.g. pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis). Severe ear, nose and throat infections (e.g. otitis media, mastoiditis). Urinary tract (e.g. acute and chronic pyelonephritis, pyelitis, cystitis - bacterial only; infections associated with bladder and renal stones). Skin and soft tissue (e.g. erysipelas abscesses, cellulitis, infected burns and wounds, mastitis). Gastrointestinal and abdominal (e.g. intra-abdominal abscesses, enterocolitis). Bone and joint (e.g. osteitis, osteomyelitis, septic arthritis, infected burstis).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store below 25 degrees Celsius
- Protect from Light
- Lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Clear glass vial with aluminium cap and plastic "flip-offs" containing a white to cream powder.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient ceftazidime
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)